Presence of CD4+ T suppressor cells in mice rendered unresponsive to tumor antigens by intravenous injection of irradiated tumor cells

We used in vivo and in vitro assays to determine whether suppressor cells are generated in mice rendered unresponsive to tumor‐specific antigens by intravenous (i.v.) injection of non‐replicating tumor cells. The results show that a single i.v. injection of 2 × 107 irradiated P815 tumor cells resulted in the induction of a state of specific unresponsiveness to tumor‐associated antigens, as revealed by the inability of the treated mice to achieve immunologically‐mediated regression of an intradermal P8 15 tumor containing C. parvum, or to generate effector T cells capable of causing rejection of a P815 tumor in T‐cell‐deficient (T × B) test recipients. Failure to respond to tumor antigens was associated with the presence in spleen of CD4+ T cells capable, on passive transfer, of suppressing adoptive T‐cell‐mediated tumor regression in T × B recipients. However, the same CD4+ suppressor cells failed to inhibit the generation of tumor‐specific cytotoxic T lymphocytes (CTL) in vitro. On the contrary, spleen cells from mice made unresponsive by i.v. injection of tumor cells were primed to generate CTL in response to tumor antigens in vitro. Taken together, our results suggest that unresponsiveness induced by i.v. injection of tumor antigens is an active process mediated, at least in part, by CD4+ T suppressor cells, and that these cells coexist in the spleen with antigen‐primed effector T cells with a capacity to generate tumor‐specific CTL when released from suppression in vitro.

[1]  Streilein Jw,et al.  In vitro suppression of cytotoxic T cell generation by lymphocytes from mice rendered neonatally tolerant of class II MHC alloantigens. , 1991 .

[2]  B. Hall,et al.  Induction of unresponsiveness to Heymann's nephritis: inhibited by monoclonal antibody to CD4 but not to CD8. , 1991, Cellular immunology.

[3]  G. Clunie,et al.  T suppressor cells induced by transfusions and cyclosporine. Studies in the murine cardiac allograft model. , 1990, Transplantation.

[4]  M. Awwad,et al.  Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma. , 1990, Immunology.

[5]  R J North,et al.  Radiosensitive barrier to T-cell-mediated adoptive immunotherapy of established tumors. , 1990, Cancer research.

[6]  B. Hall,et al.  Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action , 1990, The Journal of experimental medicine.

[7]  A. Kang,et al.  A CD4 cell is capable of transferring suppression of collagen-induced arthritis. , 1989, Journal of immunology.

[8]  W. Karpus,et al.  CD4+ suppressor cells differentially affect the production of IFN-gamma by effector cells of experimental autoimmune encephalomyelitis. , 1989, Journal of immunology.

[9]  R. Palmiter,et al.  Tolerance in transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells , 1989, The Journal of experimental medicine.

[10]  N. Chakraborty,et al.  Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma , 1989, The Journal of experimental medicine.

[11]  M. Awwad,et al.  Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell- mediated immunity , 1988, The Journal of experimental medicine.

[12]  M. Awwad,et al.  Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden. , 1988, Immunology.

[13]  R. North Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells , 1986, The Journal of experimental medicine.

[14]  H. Bear Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens. , 1986, Cancer research.

[15]  E. Dye The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells. , 1986, Journal of immunology.

[16]  C. Van Waes,et al.  Multiple cancers. Tumor burden permits the outgrowth of other cancers , 1985, The Journal of experimental medicine.

[17]  R. North,et al.  Ly 1+2- suppressor T cells down-regulate the generation of Ly 1-2+ effector T cells during progressive growth of the P815 mastocytoma. , 1985, Immunology.

[18]  K. Heeg,et al.  Analysis of immunological tolerance to major histocompatibility complex antigens. I. High frequencies of tolerogen‐specific cytotoxic T lymphocyte precursors in mice neonatally tolerized to class I major histocompatibility complex antigens , 1985, European journal of immunology.

[19]  I. Bursuker,et al.  Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells , 1984, The Journal of experimental medicine.

[20]  G. Nossal Cellular mechanisms of immunologic tolerance. , 1983, Annual review of immunology.

[21]  R. North,et al.  T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases , 1981, The Journal of experimental medicine.

[22]  R. North,et al.  Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations , 1981, The Journal of experimental medicine.